Break Free With The
Only 6-Month CGM
Do You Manage Diabetes With Multiple Daily Insulin Doses?
If so, you may benefit from the Eversense E3 Continuous Glucose Monitoring System. Please complete this form so we can tell you more about Eversense E3 and how this system might help you. We will also look into eligibility and insurance coverage, at no obligation to you.
You'll hear back from an Ascensia Diabetes Care representative soon.
The New Eversense E3 CGM System
*The opinions expressed belong solely to the individual. This information provides general information only. It is not intended to be used as medical advice, diagnosis or treatment and should not replace the advise of a health care provider.
†Exceptional accuracy over 6 months.
**There is no glucose data generated when the transmitter is removed.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For safety information, click here.
